Wednesday, 16 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14398
Articles
Company
Deals
Luzhu Bio Files for Hong Kong IPO After RMB 4.42 Billion Valuation
March 4, 2025
Company
Deals
Youwe Bio’s Series B Financing to Advance Microneedle Technology Commercialization
March 4, 2025
Policy / Regulatory
NHSA Updates NRDL with Focus on Expert Review and Simplified Renewals
March 4, 2025
Company
Drug
Ascletis Pharma Doses First Patient in China’s Phase II Trial for HIV-1 Treatment with ASC22
March 19, 2025
Company
Drug
Jixing Pharmaceuticals’ Aficamten Receives CDE Approval for Phase III HCM Study
March 19, 2025
Company
Drug
BDgene Advances CRISPR-Based BD111 for Herpes Keratitis with IND Filing
March 19, 2025
Company
Deals
MicroPort NeuroTech Lists in Hong Kong with $43.3 Million IPO
March 19, 2025
Company
Drug
Bayer’s Kerendia Approved by China’s NMPA for Diabetic Kidney Disease
March 19, 2025
Company
Drug
Hengrui Medicine’s SHR3680 Approved for High Burden Metastatic Prostate Cancer
March 19, 2025
Company
Deals
Legend Biotech Collaborates with Trinity College Dublin on CAR-T Therapies for Solid Tumors
March 19, 2025
Company
Deals
AnchorDx and West China Hospital Collaborate on Lung Cancer Early Diagnosis
March 19, 2025
Company
Drug
Akeso Biopharma’s Cadonilimab Approved for Cervical Cancer Treatment
March 19, 2025
1
2
…
1,184
1,185
1,186
1,187
1,188
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?